Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
开发视锥细胞为主的视网膜疾病模型作为转化视觉研究的资源
基本信息
- 批准号:10013200
- 负责人:
- 金额:$ 125.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAllelesAnatomyAnimal ModelAnimalsAreaBCL9 geneBiological AssayBiological ModelsBrain regionCell SurvivalCellsChemicalsCollaborationsColorCommunitiesConeDataDevelopmentDiscriminationDiseaseDisease modelDominant-Negative MutationEmbryoEvaluationEyeFunctional Magnetic Resonance ImagingFunctional disorderGene MutationGenesGenomeGoalsHibernationHumanImageIn VitroIndividualLogisticsMammalsMediatingMethodsMicromanipulationModelingMolecular GeneticsMorphogenesisMosaicismMusMutationMyopiaNatural regenerationNeuronsOrganoidsPatientsPhenotypePhotoreceptorsPhototransductionPluripotent Stem CellsPrimatesProcessProtocols documentationRattusRecombinant adeno-associated virus (rAAV)Recording of previous eventsResolutionResourcesRetinaRetinal ConeRetinal DegenerationRetinal DetachmentRetinal DiseasesRodRodentRodent ModelScandentiaSignal TransductionSpermophilusStem Cell ResearchStructureStudy modelsTechniquesTechnologyTestingTherapeuticTransgenic OrganismsTranslationsTransplantationTupaiidaeValidationVisionVision researchVisualVisual CortexVisual system structureWorkadaptive optics scanning laser ophthalmoscopyarea striatacone-rod dystrophy densitydisease phenotypefovea centralisgenetic manipulationhuman diseasehuman modelimaging modalityin vivoinduced pluripotent stem cellinnovationinterestmodel developmentmonolayermultidisciplinarynonhuman primatenovel therapeuticsoverexpressionregenerativeregenerative therapyrelating to nervous systemreproductiveretinal imagingstem cell therapytooltool developmenttreatment strategytwo-photonvisual informationvisual processing
项目摘要
PROJECT SUMMARY/ABSTRACT .
The NEI’s Audacious Goal Initiative (launched in 2012) put forward the challenge of “restoring usable vision in
humans by regenerating neurons and neural connections in the eye and visual system.” While there is an obvious
affinity towards novel therapies, current resource and technology gaps preclude translation of many therapeutic
approaches. One such gap pertains to the availability of animal models that share key features of human retinal
anatomy, as well as disease models that faithfully emulate the mechanisms and processes seen in patients with
retinal degenerations (blinding diseases that might be amenable to regenerative therapies). The absence of
readily available cone-dominant mammalian models represents a major technology gap impeding efforts
to develop and evaluate regenerative treatment strategies in the retina. We propose to advance two
promising model systems that are closer to human visual anatomy and function than the more widely used
mouse and rat models. The first is the 13-lined ground squirrel (13-LGS): a diurnal, cone-dominant rodent (~85%
cones) with large brain regions dedicated to processing visual information. The second is the tree shrew: a non-
rodent, primate-like mammal that is also cone dominant (~95% cones). These models have been used to study
visual transduction (13-LGS), outer segment morphogenesis, shedding, and remodeling during hibernation (13-
LGS), cone-bipolar cell circuitry (13-LGS), myopia (tree shrew) and central visual processing (tree shrew).
However, their use as translation-enabling models for evaluating both survival and integration of regenerated
cone photoreceptors has been limited; mainly due to a lack of tools that allow for genetic manipulation of these
animals (and thus a dearth of disease models). We propose to advance these species as disease-relevant
models through the following Specific Aims: (1) Develop, optimize, and validate imaging methods and functional
assays for the 13-LGS and tree shrew; (2) Generate 13-LGS and tree shrew cone photoreceptors from iPSCs
in vitro; (3) Create rAAV-mediated retinal degeneration models for the 13-LGS and tree shrew in vivo; (4) Enable
germline transgenic 13-LGS models of human disease; (5) Test and optimize integration of transplanted 13-
LGS, tree shrew, and human iPSC-derived cones in normal and degenerated 13-LGS and tree shrew retinas. A
key feature of this proposal is the validation of these models by comparing their cellular-resolution phenotype
with that seen in patients with similar conditions/mutations. Throughout the project, we will share and disseminate
our protocols, methods, and data to provide resources for use by the broader vision research community; this
will be done using existing and newly-created online tools. A major strength of this application is the
multidisciplinary team that has been assembled to take on this challenging project. The team brings the
necessary complementary expertise required for model development, stem cell treatment, and evaluation of cell
survival, integration, & function. This work will have a significant positive impact by providing not only validated
disease models but also generalizable tools with which to create additional models in these and other species.
项目总结/摘要。
NEI的大胆目标倡议(2012年启动)提出了“恢复可用视力”的挑战。
通过再生眼睛和视觉系统中的神经元和神经连接来治疗人类。”虽然有一个明显的
由于对新疗法的亲和力,目前的资源和技术差距阻碍了许多治疗方法的转化,
接近。一个这样的差距涉及到动物模型的可用性,这些动物模型具有人类视网膜的关键特征,
解剖,以及疾病模型,忠实地模仿在患者中看到的机制和过程,
视网膜变性(可能适合再生疗法的致盲疾病)。没有
现有的锥优势哺乳动物模型是一个主要的技术差距,阻碍了努力
开发和评估视网膜再生治疗策略。我们建议提前两个月
比更广泛使用的模型系统更接近人类视觉解剖结构和功能的有前途的模型系统
小鼠和大鼠模型。第一种是13线地松鼠(13-LGS):一种白天活动的、以锥体为主的啮齿动物(约85%)。
视锥细胞),具有专门处理视觉信息的大的大脑区域。第二种是树鼩:一种非-
啮齿类、灵长类哺乳动物,也是视锥占优势(约95%视锥)。这些模型被用来研究
视觉传导(13-LGS)、外节形态发生、脱落和冬眠期间的重塑(13-LGS)
LGS)、视锥双极细胞回路(13-LGS)、近视(树鼩)和中枢视觉处理(树鼩)。
然而,将其用作评估再生植物的存活和整合的预防模型,
视锥光感受器是有限的;主要是由于缺乏允许对这些进行遗传操纵的工具。
动物(因此缺乏疾病模型)。我们建议将这些物种作为与疾病相关的物种
模型通过以下具体目标:(1)开发,优化和验证成像方法和功能
(2)从iPSC产生13-LGS和树鼩视锥光感受器
(3)建立rAAV介导的13-LGS和树鼩视网膜变性的体内模型;(4)
人类疾病的生殖系转基因13-LGS模型;(5)测试和优化移植的13-LGS的整合;
LGS,树和人类iPSC衍生的锥在正常和退化的13-LGS和树视网膜。一
该建议的一个关键特征是通过比较这些模型的细胞分辨率表型来验证它们
与在具有类似病症/突变的患者中观察到的相同。在整个项目中,我们将分享和传播
我们的协议,方法和数据,为更广泛的视觉研究社区提供资源;这
将使用现有的和新创建的在线工具完成。此应用程序的主要优点是
我们已经组建了一个多学科团队来承担这个具有挑战性的项目。团队带来了
模型开发、干细胞治疗和细胞评估所需的必要补充专业知识
生存、整合和功能。这项工作将产生重大的积极影响,不仅提供验证
疾病模型,但也可用于在这些和其他物种中创建其他模型的可推广工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Carroll其他文献
Joseph Carroll的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Carroll', 18)}}的其他基金
Retinal Contributions to Vision Loss in Albinism
视网膜对白化病视力丧失的影响
- 批准号:
10652487 - 财政年份:2022
- 资助金额:
$ 125.56万 - 项目类别:
Retinal Contributions to Vision Loss in Albinism
视网膜对白化病视力丧失的影响
- 批准号:
10464283 - 财政年份:2022
- 资助金额:
$ 125.56万 - 项目类别:
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
开发视锥细胞为主的视网膜疾病模型作为转化视觉研究的资源
- 批准号:
10477216 - 财政年份:2018
- 资助金额:
$ 125.56万 - 项目类别:
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
开发视锥细胞为主的视网膜疾病模型作为转化视觉研究的资源
- 批准号:
10631293 - 财政年份:2018
- 资助金额:
$ 125.56万 - 项目类别:
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
开发视锥细胞为主的视网膜疾病模型作为转化视觉研究的资源
- 批准号:
10238804 - 财政年份:2018
- 资助金额:
$ 125.56万 - 项目类别:
Platform Technologies for Microscopic Retinal Imaging: Development & Translation
显微视网膜成像平台技术:开发
- 批准号:
9059095 - 财政年份:2015
- 资助金额:
$ 125.56万 - 项目类别:
Platform Technologies for Microscopic Retinal Imaging: Development & Translation
显微视网膜成像平台技术:开发
- 批准号:
8912125 - 财政年份:2015
- 资助金额:
$ 125.56万 - 项目类别:
Retinal Versus Cortical Contributions to Vision Loss in Albinism
视网膜与皮质对白化病视力丧失的影响
- 批准号:
9388351 - 财政年份:2014
- 资助金额:
$ 125.56万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 125.56万 - 项目类别:
Continuing Grant